Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Effective Control of Mismatched Alloreactivity Via Ex Vivo Alloantigen specific Costimulatory Blockade Does Not Significantly Impact Pathogen Specific Immunity

Effective Control of Mismatched Alloreactivity Via Ex Vivo Alloantigen specific Costimulatory Blockade Does Not Significantly Impact Pathogen Specific Immunity. Effective Control of Mismatched Alloreactivity Via Ex Vivo Alloantigen specific Costimulatory Blockade Does Not Significantly Impact Pathogen Specific Immunity. 2006; 108(11):3177.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.